4Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience [J]. Int J Radiat Oneol Biol Phys, 2002,53 ( 1 ) : 12-22.
5Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience [J]. Int J Radiat Oncol Biol Phys, 2004,60(5) : 1440-1450.
6Lee AW, Sze WM, Au JS, et al. Treatment results tor nasopharyngeal carcinoma in the modern era: The Hong Kong experience [J]. Int J Radiat Oncol Biol Phys, 2005,61(4): 1107-1116.
7Chau RM, Teo PM, Kam MK, et al. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brain and spinal cord [J]. Med Dosim, 2007,32(4):263-270.
8Waldron J, Tin MM, Keller A, et al. Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma [J]. Radiother Oncol, 2003,68 (2):153-161.
9Kam MK, Chau RM, Suen J, et al. Intenslty-modulated radiotherapy in nasopharyngeal carcinoma: dosimetrie advantage over conventional plans and feasibility of dose escalation[J]. Int J Radiat Oncol Biol Phys, 2003,56(1): 145-157.
10Vald6s Olmos RA, Keus RB, Takes RP, et al. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands [J]. Cancer, 1994,73(12) : 2886-2893.
